Erzsébet Mernyák | Bioorganic Chemistry | Best Researcher Award

Published on by Global Scholar Awards

Assist. Prof. Dr. Erzsébet Mernyák | Bioorganic Chemistry | Best Researcher Award

Senior Researcher at University of Szeged, Hungary

Dr. Erzsébet Mernyák is a Hungarian organic chemist whose research bridges synthetic chemistry and pharmaceutical science. With over two decades of academic and research experience, she has made significant contributions to the synthesis of biologically active compounds, particularly in the area of photosensitizers, steroidal derivatives, and fluorescent-labeled molecules. She currently serves as an Assistant Professor at the University of Szeged, Hungary. Her work is widely published in high-impact journals such as the International Journal of Molecular Sciences and European Journal of Pharmaceutical Sciences, often in collaboration with interdisciplinary and international teams. Dr. Mernyák has received multiple prestigious grants and awards that reflect her excellence in both research and education. Recognized for her dedication to student mentorship, she has also earned the “Golden Chalk Prize” from the Faculty of Natural Sciences and Informatics. Her continued innovation and leadership make her a valuable asset to the scientific community in Hungary and beyond.

Professional Profile 

Education🎓

Dr. Erzsébet Mernyák’s academic journey is rooted in the prestigious University of Szeged, where she earned her Ph.D. in Chemistry in 2002, specializing in the Organic Chemistry Subprogram of the Doctoral School of Chemistry. Her earlier academic foundation was laid at József Attila University, also in Szeged, where she obtained her M.Sc. in Chemistry in 1999. Her doctoral studies focused on synthetic methodologies and structural analysis of complex organic molecules, setting the stage for a research career that would later explore various branches of pharmaceutical and medicinal chemistry. This solid academic training, particularly in fundamental and applied organic chemistry, has allowed her to develop a robust understanding of both classical and modern techniques in organic synthesis. Her advanced education continues to support her current interdisciplinary research, which often integrates aspects of spectroscopy, molecular pharmacology, and bioorganic chemistry, highlighting her firm grounding in both theory and practical application.

Professional Experience📝

Dr. Mernyák has built a progressive and dedicated academic career at the University of Szeged, starting as a Research Assistant in 2002. Over the years, she has held multiple research-focused positions, including OTKA Postdoctoral Researcher (2005), Research Fellow (2010), and currently, Assistant Professor since 2017. Her career trajectory reflects a sustained commitment to scholarly advancement and innovation in organic chemistry. She has played a central role in various collaborative research projects, many of which resulted in peer-reviewed publications and national conference presentations. In addition to her research duties, she has consistently contributed to teaching and mentoring, which is recognized through student-nominated awards like the “Golden Chalk Prize.” Through these roles, Dr. Mernyák has not only contributed to scientific inquiry but has also helped shape the next generation of chemists. Her experience exemplifies a balanced blend of research excellence, educational leadership, and academic service.

Research Interest🔎

Dr. Erzsébet Mernyák’s research interests lie at the interface of organic synthesis and pharmaceutical applications. She specializes in designing and synthesizing bioactive molecules, such as flavonoid derivatives, steroidal compounds, and photosensitizers with potential therapeutic and diagnostic uses. Her recent focus includes developing BODIPY-based fluorescent dyes and estradiol conjugates for biological imaging and drug delivery systems. Additionally, she explores site-selective functionalization techniques, including C–H and O–H activation, which are crucial in the sustainable modification of complex molecules. Dr. Mernyák is particularly interested in compounds that exhibit anticancer or hormone-regulating properties, bridging synthetic chemistry with medicinal applications. Her interdisciplinary research is often conducted in collaboration with pharmacologists, biochemists, and international researchers. These pursuits not only advance chemical understanding but also have real-world biomedical implications. With a clear focus on innovation and translational potential, her research addresses critical scientific questions in drug design and chemical biology.

Award and Honor🏆

Dr. Mernyák’s outstanding work in research and education has been recognized through numerous national awards and competitive research grants. Notably, she has received the Bolyai János Research Grant twice (2003, 2016), awarded by the Hungarian Academy of Sciences, reflecting her long-term impact and consistency in high-quality research. She was also awarded the Magyary Zoltán Postdoctoral Grant in 2013, further supporting her innovative contributions to organic synthesis. Between 2017 and 2019, she was honored with the New National Excellence Grant three years in a row, a testament to her ongoing relevance and productivity in academic research. In recognition of her teaching and mentorship, she earned the Golden Chalk Prize in both 2017 and 2023. Another major milestone was receiving the Zemplén Géza Award in 2015, a prestigious acknowledgment from the Hungarian Academy of Sciences. These accolades collectively reflect her multidimensional excellence in research, education, and scientific contribution.

Research Skill🔬

Dr. Mernyák brings an advanced and diverse set of research skills to the field of organic and medicinal chemistry. She is proficient in multistep organic synthesis, structure elucidation, and molecular characterization using spectroscopic methods like NMR, UV-Vis, and mass spectrometry. Her skill in designing fluorescent molecular probes and photoactive compounds makes her a valuable contributor to interdisciplinary pharmaceutical research. She has deep expertise in C–H activation techniques, which are cutting-edge strategies in sustainable chemistry for modifying complex molecules. Additionally, she is experienced in collaborating with biologists and pharmacologists to conduct biological evaluations of synthesized compounds, particularly those with antiproliferative or estrogenic activity. Her familiarity with Q1/Q2-ranked journal publishing, research documentation, and conference presentation further showcases her ability to communicate complex scientific concepts effectively. Overall, Dr. Mernyák’s research skills not only span technical synthesis but also encompass interdisciplinary collaboration, project management, and knowledge translation into real-world applications.

Conclusion💡

Dr. Erzsébet Mernyák is a highly deserving candidate for the Best Researcher Award, with significant and sustained contributions to organic and medicinal chemistry. Her pioneering work in synthesizing bioactive molecules with potential therapeutic applications, alongside consistent academic excellence, national recognition, and multidisciplinary collaborations, positions her as a leading figure in Hungarian and European chemical research. With continued momentum, she is likely to play a pivotal role in future drug discovery efforts and academic leadership.

Publications Top Noted✍️

  • Synthesis and investigation of the anticancer effects of estrone-16-oxime ethers in vitro
    • Authors: Á. Berényi, R. Minorics, Z. Iványi, I. Ocsovszki, E. Ducza, H. Thole, et al.
    • Year: 2013
    • Cited by: 80

  • Neighboring group participation: Part 15. Stereoselective synthesis of some steroidal tetrahydrooxazin-2-ones, as novel presumed inhibitors of human 5α-reductase
    • Authors: J. Wölfling, L. Hackler, E. Mernyák, G. Schneider, I. Tóth, M. Szécsi, J. Julesz, et al.
    • Year: 2004
    • Cited by: 65

  • Synthesis and receptor-binding examinations of the normal and 13-epi-D-homoestrones and their 3-methyl ethers
    • Authors: J. Wölfling, E. Mernyák, É. Frank, G. Falkay, Á. Márki, R. Minorics, et al.
    • Year: 2003
    • Cited by: 56

  • Synthesis of Artemisinin–Estrogen Hybrids Highly Active against HCMV, P. falciparum, and Cervical and Breast Cancer
    • Authors: T. Fröhlich, A. Kiss, J. Wölfling, E. Mernyák, A. E. Kulmány, R. Minorics, et al.
    • Year: 2018
    • Cited by: 52

  • Synthesis of trans-16-triazolyl-13α-methyl-17-estradiol diastereomers and the effects of structural modifications on their in vitro antiproliferative activities
    • Authors: E. Mernyák, I. Kovács, R. Minorics, P. Sere, D. Czégány, I. Sinka, J. Woelfling, et al.
    • Year: 2015
    • Cited by: 51

  • Antiproliferative effect of normal and 13-epi-D-homoestrone and their 3-methyl ethers on human reproductive cancer cell lines
    • Authors: R. Minorics, N. Bozsity, J. Woelfling, E. Mernyák, G. Schneider, A. Marki, et al.
    • Year: 2012
    • Cited by: 40

  • Stereoselective synthesis of spiro and condensed pyrazolines of steroidal α, β-unsaturated ketones and nitrilimines by 1,3-dipolar cycloaddition
    • Authors: E. Mernyák, E. Kozma, A. Hetényi, L. Márk, G. Schneider, J. Wölfling
    • Year: 2009
    • Cited by: 40

  • Stereoselective synthesis of some 17β-dihydrooxazinyl steroids, as novel presumed inhibitors of 17α-hydroxylase-C17,20-lyase
    • Authors: J. Wölfling, É. A. Oravecz, D. Ondré, E. Mernyák, G. Schneider, I. Tóth, et al.
    • Year: 2006
    • Cited by: 39

  • Synthesis and biological evaluation of 13α-estrone derivatives as potential antiproliferative agents
    • Authors: J. Szabó, Z. Pataki, J. Wölfling, G. Schneider, N. Bózsity, R. Minorics, I. Zupkó, et al.
    • Year: 2016
    • Cited by: 38

  • Synthesis and structure–activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis
    • Authors: I. Bacsa, B. E. Herman, R. Jójárt, K. S. Herman, J. Wölfling, G. Schneider, et al.
    • Year: 2018
    • Cited by: 37

Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Published on by Global Scholar Awards

Prof. Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Professor and Deputy Registrar at Anurag University, India

Dr. Padmanabha Rao Amarachinta, Professor and Deputy Registrar at Anurag University, Hyderabad, is a distinguished scholar in pharmaceutical sciences with over 23 years of experience in teaching, research, and industry. He holds a Ph.D. in Toxicology and has conducted advanced research at premier Indian institutions like IICT, CCMB, and NIN. Dr. Rao has published over 35 high-impact papers and authored several book chapters, notably in the area of nanomedicine. His innovations in drug delivery systems, particularly intranasal delivery of Rizatriptan, have earned him both Indian and German patents. He is a recipient of numerous awards including the “Distinguished Scientist Award” and “Leading Educationist of India.” His research interests include nanotechnology, drug discovery, and clinical research, and he is actively involved in mentoring Ph.D. scholars. Dr. Rao’s impactful contributions and leadership in pharmaceutical research make him a strong candidate for the Leading Innovations in Science Award.

Professional Profile 

Education🎓

Dr. Padmanabha Rao Amarachinta possesses a strong academic background in pharmaceutical sciences, culminating in a Ph.D. in Toxicology. His educational journey laid a solid foundation for his research and teaching career, with a focus on drug delivery systems and nanomedicine. Throughout his academic training, Dr. Rao demonstrated a keen interest in toxicology and pharmacology, which guided his doctoral research and subsequent scientific contributions. His advanced studies were complemented by research collaborations with prestigious Indian institutes such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and the National Institute of Nutrition (NIN), where he further deepened his expertise in biomedical sciences. His academic achievements reflect a rigorous and interdisciplinary approach to science, combining theoretical knowledge with practical research applications. Dr. Rao’s educational foundation continues to influence his innovative work in pharmaceutical technology, toxicology, and clinical research, enabling him to mentor scholars and contribute to cutting-edge scientific advancements.

Professional Experience📝

Dr. Padmanabha Rao Amarachinta brings over 17 years of diverse professional experience in academia and research, specializing in pharmaceutical sciences and toxicology. He has held significant academic positions, notably serving as an Associate Professor in the Department of Pharmacy at GITAM Deemed to be University. Dr. Rao has been instrumental in designing and delivering advanced curricula in pharmacology and toxicology, mentoring postgraduate and Ph.D. scholars, and fostering a research-driven academic environment. His professional journey includes collaborative research projects with prestigious institutions such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and National Institute of Nutrition (NIN). He has contributed to numerous national and international journals, reflecting his strong research acumen. Dr. Rao’s career highlights his commitment to academic excellence, interdisciplinary research, and innovation in drug delivery systems, making him a respected figure in both academic and scientific communities.

Research Interest🔎

Dr. Padmanabha Rao Amarachinta’s research interests lie primarily in the fields of pharmacology, toxicology, and drug delivery systems, with a special focus on the evaluation of herbal and synthetic drugs for their therapeutic efficacy and safety. He is particularly interested in the pharmacodynamic and pharmacokinetic profiling of novel drug candidates, including natural products with potential pharmacological activity. Dr. Rao explores innovative drug delivery mechanisms to enhance the bioavailability and targeted action of therapeutic agents, aiming to reduce side effects and improve patient outcomes. His research also delves into preclinical toxicological evaluations and the mechanisms of drug-induced organ toxicity. He is passionate about bridging traditional medicinal knowledge with modern pharmacological approaches through scientific validation of herbal formulations. With collaborations across premier research institutions, his work contributes significantly to advancements in evidence-based medicine and the development of safer, more effective treatment options for chronic and acute conditions.

Award and Honor🏆

Dr. Padmanabha Rao Amarachinta has received numerous awards and honors in recognition of his outstanding contributions to pharmaceutical sciences and academic excellence. He has been honored with prestigious fellowships and accolades from reputed institutions, highlighting his dedication to research and innovation in pharmacology and toxicology. Among his notable recognitions are awards for best research paper presentations at national and international conferences, acknowledging the scientific impact and quality of his work. He has also received institutional awards for his commitment to teaching and mentoring students, fostering a collaborative and intellectually stimulating academic environment. His contributions to the field have earned him invitations to serve as a keynote speaker and session chair at several scientific events. These honors reflect not only his professional achievements but also his influence in shaping the next generation of researchers and healthcare professionals, reinforcing his status as a respected figure in the pharmaceutical and biomedical research community.

Research Skill🔬

Dr. Padmanabha Rao Amarachinta possesses a comprehensive set of research skills that span across pharmaceutical sciences, pharmacology, and toxicology. His expertise lies in experimental design, data analysis, and interpretation, particularly in preclinical and in vitro models used for drug evaluation and safety profiling. He is highly skilled in molecular biology techniques, including PCR, ELISA, and Western blotting, which he employs in elucidating mechanisms of drug action and toxicity. Dr. Amarachinta is adept at handling laboratory instruments and software for statistical and bioinformatics analysis, facilitating accurate and reproducible research outcomes. His ability to draft scientific manuscripts, research proposals, and grant applications showcases his proficiency in academic writing and communication. Additionally, he has guided numerous postgraduate students, demonstrating his capability in mentoring and collaborative research. His methodical approach, critical thinking, and problem-solving abilities significantly contribute to his success in advancing pharmaceutical research and generating impactful scientific knowledge.

Conclusion💡

Dr. Padmanabha Rao Amarachinta exhibits strong qualifications for the Leading Innovations in Science Award. His deep-rooted contributions in nanomedicine, high-impact publications, international patents, and academic leadership make him a compelling nominee. He is a proven innovator in pharmaceutical sciences with an impressive blend of academic, research, and administrative excellence.

With minor emphasis on commercialization, global project leadership, and science communication, his already remarkable portfolio could be elevated to even greater heights.

Publications Top Noted✍️

  • Title: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
    Authors: PR Amarachinta, G Sharma, N Samed, AK Chettupalli, M Alle, JC Kim
    Year: 2021
    Citations: 77

  • Title: Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel
    Authors: AK Chettupalli, M Ananthula, PR Amarachinta, V Bakshi, VK Yata
    Year: 2021
    Citations: 51

  • Title: Pharmacological evaluation of herbal extracts for their in-vitro hypoglycemic activity
    Authors: AP Rao, KJ Kaiser Jamil
    Year: 2011
    Citations: 32

  • Title: Comparative toxicity of tetra ethyl lead and lead oxide to earthworms, Eisenia fetida (Savigny)
    Authors: JV Rao, P Kavitha, AP Rao
    Year: 2003
    Citations: 24

  • Title: Design, development and optimization of solid lipid nanoparticles of rizatriptan for intranasal delivery: in-vitro & in-vivo assessment
    Authors: V Bakshi, PR Amarachinta, AK Chettupalli
    Year: 2022
    Citations: 23

  • Title: Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
    Authors: A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani, AM Bannunah, …
    Year: 2023
    Citations: 17

  • Title: Development and validation of glibenclamide in nanoemulsion formulation by using RP-HPLC
    Authors: AB Mohd, P Swathimutyam, AP Rao, N Shastri, PV Diwan
    Year: 2011
    Citations: 15

  • Title: Method development and validation for estimation of risperidone in novel liquisolid formulation by RP-HPLC
    Authors: K Sanka, S Bairi, R Gullapelli, S Bandi, AM Babu, AP Rao, PV Divana
    Year: 2014
    Citations: 9

  • Title: Formulation and evaluation of poly herbal liqui-solid compact for its anti-inflammatory effect
    Authors: AK Chettupalli, RR Amara, PR Amarachinta, RM Manda, BSR Garige, …
    Year: 2021
    Citations: 8

  • Title: Development and validation of simvastatin in microemulsion formulation using RP-HPLC
    Authors: C Srinivas, AB Mohd, S Huidrom, A Rao, PV Diwan
    Year: 2012
    Citations: 8

  • Title: Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route
    Authors: AK Chettupalli, S Ajmera, PR Amarachinta, RM Manda, RK Jadi
    Year: 2023
    Citations: 6

  • Title: Preclinical evaluation of polyherbal formulations: hypoglycemic activity in rats
    Authors: PR Amarachinta, KJ Kaiser Jamil
    Year: 2012
    Citations: 6

  • Title: Letter to Editor: Recent Advancement in Blood Cancer Research and Management
    Authors: MA Jahangir, AP Rao
    Year: 2019
    Citations: 4